‘A little bit of an overreaction’

Abbott Laboratories CEO Robert Ford unpacked his company’s latest quarterly report in a Thursday interview with CNBC’s Jim Cramer, saying that Wall Street’s reaction to the results was extreme. “I think this is a little bit of an overreaction. Of course, we are all over this,” Ford said. “We’re focused on this, but the fundamentals…

Read More

It’s all about the guidance

Shares of Abbott Laboratories fell Thursday after the diversified health-care company delivered a solid second quarter but left investors disappointed with forward guidance. Revenue in the three months ended June 30 rose 7.4% to $11.14 billion, outpacing the $11.07 billion consensus estimate, according to estimates compiled by LSEG. Organic sales , excluding Covid testing results,…

Read More

Coinbase steps into consumer market with stablecoin-powered ‘everything app’ that goes beyond trading

Dominika Zarzycka | Nurphoto | Getty Images Coinbase unveiled Wednesday an “everything app” designed to bring more people into the crypto economy. The “Base App,” which replaces Coinbase Wallet, will combine wallet, trading and payment functions as well as social media, messaging and support for mini apps – all running on the company’s homegrown public…

Read More